EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Aberrant fragmentomic features of circulating cell-free mitochondrial DNA enable early detection and prognosis prediction of hepatocellular carcinoma

Yang Liu, Fan Peng, Siyuan Wang, Huanmin Jiao, Kaixiang Zhou, Wenjie Guo, Shanshan Guo, Miao Dang, Huanqin Zhang, Weizheng Zhou, Xu Guo, Jinliang Xing

Clinical and Molecular Hepatology · 2025

DOI: 10.3350/cmh.2024.0527 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Molecular Hepatology, 2025. Verfasst von Yang Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and Department of Physiology and Pathophysiology, Fourth Military…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, DNA, Mitochondrial, Cell-Free Nucleic Acids. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: National Natural Science Foundation of China, Science & Technology Co-ordination and Innovation Project of Shaanxi Province, Air Force Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aims: Early detection and effective prognosis prediction in patients with hepatocellular carcinoma (HCC) provide an avenue for survival improvement, yet more effective approaches are greatly needed. We sought to develop the detection and prognosis models with ultra-sensitivity and low cost based on fragmentomic features of circulating cell free mtDNA (ccf-mtDNA).

Methods

Capture-based mtDNA sequencing was carried out in plasma cell-free DNA samples from 1168 participants, including 571 patients with HCC, 301 patients with chronic hepatitis B or liver cirrhosis (CHB/LC) and 296 healthy controls (HC).

Results

The systematic analysis revealed significantly aberrant fragmentomic features of ccf-mtDNA in HCC group when compared with CHB/LC and HC groups. Moreover, we constructed a random forest algorithm-based HCC detection model by utilizing ccf-mtDNA fragmentomic features. Both internal and two external validation cohorts demonstrated the excellent capacity of our model in distinguishing early HCC patients from HC and highrisk population with CHB/LC, with AUC exceeding 0.983 and 0.981, sensitivity over 89.6% and 89.61%, and specificity over 98.20% and 95.00%, respectively, greatly surpassing the performance of alpha-fetoprotein (AFP) and mtDNA copy number. We also developed an HCC prognosis prediction model by LASSO-Cox regression to select 20 fragmentomic features, which exhibited exceptional ability in predicting 1-year, 2-year and 3-year survival (AUC=0.8333, 0.8145 and 0.7958 for validation cohort, respectively).

Conclusions

We have developed and validated a high-performing and low-cost approach in a large clinical cohort based on aberrant ccf-mtDNA fragmentomic features with promising clinical translational application for the early detection and prognosis prediction of HCC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsDNA, MitochondrialCell-Free Nucleic AcidsHumansPrognosisFemaleMaleMiddle AgedHepatitis B, ChronicEarly Detection of CancerLiver CirrhosisAgedROC CurveCase-Control StudiesAdultBiomarkers, Tumor

Stichwörter der Autor:innen

Circulating cell free mitochondrial DNAEarly diagnosisFragmentomicsHepatocellular carcinomaprognosis

Substanzen

DNA, MitochondrialCell-Free Nucleic AcidsBiomarkers, Tumor

Autor:innen und Institutionen

  • State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and Department of Physiology and Pathophysiology, Fourth Military Medical University, Xi'an, China.
  • Department of Clinical Diagnosis, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.
  • Department of General Surgery, Changhai Hospital, Navy Medical University, Shanghai, China.

Förderung

  • National Natural Science Foundation of China
  • Science & Technology Co-ordination and Innovation Project of Shaanxi Province
  • Air Force Medical University

Zitieren

APA

Liu, Y., Peng, F., Wang, S., Jiao, H., Zhou, K., Guo, W., Guo, S., Dang, M., Zhang, H., Zhou, W., Guo, X., & Xing, J. (2025). Aberrant fragmentomic features of circulating cell-free mitochondrial DNA enable early detection and prognosis prediction of hepatocellular carcinoma. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2024.0527

Vancouver

Liu Y, Peng F, Wang S, Jiao H, Zhou K, Guo W, et al. Aberrant fragmentomic features of circulating cell-free mitochondrial DNA enable early detection and prognosis prediction of hepatocellular carcinoma. Clinical and Molecular Hepatology. 2025. doi:10.3350/cmh.2024.0527

BibTeX
@article{Liu2025,
  author = {Liu, Yang and Peng, Fan and Wang, Siyuan and Jiao, Huanmin and Zhou, Kaixiang and Guo, Wenjie and Guo, Shanshan and Dang, Miao and Zhang, Huanqin and Zhou, Weizheng and Guo, Xu and Xing, Jinliang},
  title = {Aberrant fragmentomic features of circulating cell-free mitochondrial DNA enable early detection and prognosis prediction of hepatocellular carcinoma},
  journal = {Clinical and Molecular Hepatology},
  year = {2025},
  doi = {10.3350/cmh.2024.0527}
}
Kostenlos starten →